June 7, 2007
Congress Holds Hearing on FDA
In fall out from the Avandia story, the House Committee on Oversight and Government Reform held a hearing yesterday on the FDA's role in evaluating drug safety. The NY Times has a full report. In a prepared statement, the FDA Commissioner stated that more prominent warnings of heart risk would be required on Avandia.
TrackBack URL for this entry:
Listed below are links to weblogs that reference Congress Holds Hearing on FDA: